As of 2025-11-06, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 138.01 USD. This relative valuation is based on P/E multiples. With the latest stock price at 71.77 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is 92.3%.
The range of the Relative Valuation is 111.36 - 179.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 18.8x | 16.2x |
| Forward P/E multiples | 14.8x - 22.7x | 18.7x |
| Fair Price | 111.36 - 179.94 | 138.01 |
| Upside | 55.2% - 150.7% | 92.3% |
| Date | P/E |
| 2025-11-04 | 8.55 |
| 2025-11-03 | 8.58 |
| 2025-10-31 | 8.62 |
| 2025-10-30 | 8.60 |
| 2025-10-29 | 8.50 |
| 2025-10-28 | 8.52 |
| 2025-10-27 | 8.47 |
| 2025-10-24 | 8.38 |
| 2025-10-23 | 8.43 |
| 2025-10-22 | 8.40 |
| 2025-10-21 | 8.48 |
| 2025-10-20 | 8.63 |
| 2025-10-17 | 8.33 |
| 2025-10-16 | 8.44 |
| 2025-10-15 | 8.65 |
| 2025-10-14 | 8.34 |
| 2025-10-13 | 8.34 |
| 2025-10-10 | 8.36 |
| 2025-10-09 | 8.33 |
| 2025-10-08 | 8.14 |
| 2025-10-07 | 8.07 |
| 2025-10-06 | 8.18 |
| 2025-10-03 | 8.25 |
| 2025-10-02 | 7.96 |
| 2025-10-01 | 7.83 |
| 2025-09-30 | 7.75 |
| 2025-09-29 | 7.66 |
| 2025-09-26 | 7.45 |
| 2025-09-25 | 7.30 |
| 2025-09-24 | 7.51 |
| 2025-09-23 | 7.65 |
| 2025-09-22 | 7.68 |
| 2025-09-19 | 7.64 |
| 2025-09-18 | 7.94 |
| 2025-09-17 | 7.66 |
| 2025-09-16 | 7.54 |
| 2025-09-15 | 7.45 |
| 2025-09-12 | 7.71 |
| 2025-09-11 | 7.70 |
| 2025-09-10 | 7.36 |
| 2025-09-09 | 7.38 |
| 2025-09-08 | 7.19 |
| 2025-09-05 | 7.23 |
| 2025-09-04 | 7.32 |
| 2025-09-03 | 7.01 |
| 2025-09-02 | 6.62 |
| 2025-08-29 | 6.23 |
| 2025-08-28 | 6.29 |
| 2025-08-27 | 6.29 |
| 2025-08-26 | 6.24 |